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Abstract
Diabetes is one of the most commonly diagnosed chronic diseases in medicine.
According to the Center for Disease Control (2020) more than 10% of the United States
population is diagnosed with diabetes, and it is the seventh leading cause of death. The most
common complications related to diabetes include heart disease, stroke, blindness, eye problems,
kidney disease, nerve damage, amputations, and wound complications (CDC, 2020). Diabetes
can also be associated with an increased risk for infection-related mortality (Li & McDermott,
2016). This literature review will focus on the potential that strict management of diabetes can
decrease the risk of infection for this population. It is well documented that diabetics are at a
higher risk for infection due to immunosuppression. However, it is not well studied within how
strict of measures we should set a goal for our patients with the aim to decrease the risk for
infection. Li & McDermott (2016) stated that in 2001 the cost of diabetic wounds cost 10.9
billion dollars and that the length of stay for diabetics with infections is on average 6 days in
comparison to 3.4 days for non-diabetics with infection. Hospitals are always looking for ways to
budget better, reduce cost, and reduce length of stay. These statistics alone stand out as reasons
to do further research on the prevention of infection in type 2 diabetics.
Search Parameters
Research was done by using the databases CINAHL and PubMed. Keywords included
“glycosylated hemoglobin”, “type 2 diabetes”, “HbA1c”, “infection”, “cellulitis” and publication
dates were set between 2015 to 2020. Recommendations from the Center for Disease Control,
the American Diabetes Association (ADA) and American Association of Clinical
Endocrinologists (AACE) were reviewed as well. Certain articles were excluded from review if
they were focused on independent variables that could affect infection or hemoglobin A1c, any
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non-English articles, articles that included only type 1 diabetes, and articles that did not use
hemoglobin A1c as the compared variable.
Background
Diabetes mellitus (DM) largely infiltrates our healthcare system and it is only projected
to expand further. There are currently 26.9 million people in the US who are diagnosed with
diabetes and it is expected that there are approximately 7.3 million people who are yet
undiagnosed (CDC, 2020). It is well studied and accepted in the literature that there is a strong
association between glycemic blood levels and the risk of developing diabetic complications
such as infection. The increased risk for infection can be attributed to elevated glucose content in
bodily fluids, which provides an ideal breeding ground for bacterial proliferation (Domek et al.,
2016).
Hemoglobin A1c (HbA1c) is a blood test utilized to assess how well the disease is being
managed. HbA1c is the glycosylated hemoglobin in the blood. It classifies the average plasma
glucose concentration over a 3-month period (Zubair & Ahmad, 2018). The American Diabetes
Association states that the goal for most adults with diabetes is a HbA1c less than 7% (American
Diabetes Association, 2020). They also state that target levels can vary by an individual’s age
and other health care factors. On the other hand, the American Association of Clinical
Endocrinologists suggest that treatment goal of T2DM is a HbA1c less than or equal to 6.5%
(AACE, 2019). This literature review will look at the concept related to which goal is best
associated with decreased infection rates, comparing HbA1C of 6.5% to 7% and higher.
The relation between glycemic control and infectious disease is not well studied
(Pearson-Stuttard et al., 2016). The focus of this document will assess HbA1c and risk for
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infection in diabetic patients. The case study that is outlined below focuses on a patient with
poorly controlled type 2 diabetes who is found to have cellulitis due to an ulceration on her leg.
Case Report
History
A 58 year-old female presented to the primary care clinic for an episodic visit due to
fever, chills, confusion and forgetfulness. The patient reported that her family had mentioned she
was more forgetful than normal. Examples given by the patient included forgetting what she ate
for breakfast, or where her car keys were. She reported that her fever had been present for a few
days. She had taken Tylenol with some relief for a brief period of time but fever would reoccur.
She cannot recount her maximum fever. She denies a cough, sore throat or ear tenderness. When
asked about her history she reports being a type 2 diabetic, having coronary artery disease and a
history of hypertension. She does not check her fasting blood sugars at home and denies a low
carbohydrate diet or regular exercise. She denied polyuria, polydipsia, or polyphagia. Unsure if
she has hypoglycemic events. Today she denies a headache or vision changes. She does not
check her blood pressure at home. She denies alcohol or tobacco use, has no pertinent surgical
history to report and her vaccinations are up to date. Family history includes hypercholesteremia
on both sides of her family. Her home medications include Zetia 5 mg one time a day, Lopressor
50 mg daily, Lisinopril 10 mg daily, Metformin 1000 mg daily, fish oil 1000 mg daily, Zocor 80
mc daily and 325 mg aspirin daily. She states she has been taking her medications as prescribed.
Physical Examination
Her vital signs during the visit were as follows: blood pressure- 194/83, heart rate- 119,
respiration rate- 14, temperature- 104.7, pulse oximetry- 93% on room air, weight- 260lb.,
height- 5’5”. On physical exam she was alert and answers all orientation questions correctly.
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Cranial nerves intact. Her pupils were equal, round and reactive to light; Conjunctiva are normal.
Her mucous membranes are pink and moist. On auscultation of her heart, she is tachycardic with
regular rhythm. No murmurs heard. Lungs are clear to auscultation to bilateral lung fields with
normal effort of breathing. No enlarged lymph nodes are palpated. Skin is warm and dry. Has
one open ulceration to left lower extremity on the anterior portion of her shin. There was no
drainage from the wound. It measures to be about 2 cm in diameter. There is redness and it feels
to be hot to the touch. Pedal pulses intact. Capillary refill to reddened area is 2 seconds. Area
surrounding wound had +2 pitting edema. No further wounds noted to the feet, soles of feet or
other extremities.
Testing
Fasting labs were ordered including a complete blood count with differential, C-Reactive
protein (CRP), lactic acid, erythrocyte sedimentation rate (ESR), HbA1c, and urinalysis. CRP
and ESR were evaluated for details regarding inflammatory processes. Pertinent findings
included an elevated white blood cell count (12.5 K/uL), elevated CRP (144 mg/dL), elevated
fasting glucose (266 mg/dL), low sodium (132 meq/L), elevated lactic acid (4.4 mmol/L), and
elevated ESR (57 mm/Hr) and a normal urinalysis. Most recent HbA1c was 9.3% three months
prior to this visit.
Diagnosis, Treatment and Plan
Diagnosis for todays visit was cellulitis to the lower extremity with uncontrolled type 2
diabetes and uncontrolled hypertension. Results were discussed with the patient. She denies
noting any ulceration prior to todays visit. She reports neuropathy to her lower extremities after
further assessment. Treatment for this patient includes a further workup and intravenous
antibiotics to be given in the Emergency Department. Common antibiotics to be used for
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cellulitis include cefazolin and ceftriaxone. This patient is immune compromised and febrile with
the known source of the infection being from her cellulitis. Discussed this plan with patient and
she is agreeable to further management with a higher level of care. She agrees to set an
appointment in clinic for one-week post hospital discharge to discuss management of her T2DM,
hypertension, and infection status.
If patient refused emergency room treatment, oral antibiotics would be initiated.
Cephalexin is first line for treatment of non-purulent cellulitis with dosing of 500 mg four times
a day for at least five days. Would give patient teaching on when to return. This would include a
new fever after current fever resolves, drawing an outline around the reddened area and told to
alert the clinic if redness spreads past the line, or worsening of systemic symptoms such as
increased confusion or fatigue. For further management for her T2DM, I would increase her
Metformin slowly. First I would add one additional 500 mg tablet to her evening meal for a total
dose of 1500mg daily. I would also schedule a recheck for another HbA1c and fasting blood
glucose in 3 months after dose changes were made. Her hypertension medication Lisinopril
would also need adjustment. I would increase her dose to 20 mg daily.
Literature Review
There are strong associations between T2DM and infection risks. Patients with T2DM are
twice as likely to be hospitalized for infections compared to those patients without it. This is
especially true for diabetics diagnosed with urinary tract infections, cellulitis, and septicemia (Li
& DcDermott, 2016). Providers in clinics are typically aiming for a goal of HbA1c of 7% but
that poses the question that if we lower HbA1c below 7%, does that decrease our risk for
infection? The relationship between glycemic control and infectious disease is not well studied
thus far (Pearson-Stuttard et al., 2016). The importance for this study remains high because it has
been estimated that $612 billion are spent annually on diabetes care (Pearson-Stuttard et al.,
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2016). If there is a possibility that more strict goals for T2DM treatment can help reduce
infections it would be more beneficial for patients but also will save US dollars. The purpose of
this literature review is to compare the concepts of infection rate and HbA1c levels to better
understand evidence supporting a patient’s HbA1c goal.
Evidence for Tighter Control
The Diabetes Control and Complications Trial (DCCT) reported infection outcomes of
patients who were subjected to either a control group, where the patients received conventional
therapy for DM, or in a group that received intensive therapy (Pearson-Stuttard et al., 2016).
Intensive therapy was defined as target ranges for blood sugars of 80-110 mg/dL, and
conventional therapy was defined at blood sugars ranging 140-180 mg/dL. These two groups
were followed up every 3 months to evaluate for infection rates. The incidence of vaginal
infections, foot infections, and foot ulcers were all reduced in the group that received intensive
therapy (Pearson-Stuttard et al., 2016). This leads to the notion that since there was a more
stringent blood sugar the patient’s HbA1c was reduced in the intensive group.
Surgical Infections
In this literature review seven of the thirteen articles included evidence showing reduced
infection rates with tighter glycemic control. This review observes all types of infections
including post-surgical infections (Cancienne et al., 2017; Domek et al., 2016; Showen et al.,
2017), wound healing after non-cardiac surgery (Chen et al., 2018), and generalized wound
infections (Li & McDermott, 2016). The most common complication in elective foot and ankle
surgeries was infection (42.3%) according to Domek et al. (2016). They found that the average
HbA1c for patients with any type of complication after surgery within 30 days was significantly
greater when compared to those without any complication. In this same study, the rate of wound
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healing complications was not significant in relation to elevated HbA1C. The most significant
finding from the study done by Domek et al., (2016) was that there was a “5% increase in the
complication rate for every 1% increase in the HbA1C”. Cancienne et al. (2017) found that the
inflection point for increased risk of infection was a HbA1C of 7.5% in their study. The study
included a range of HbA1C from 5.5 mg/dL up to levels of 11.5 mg/dL. Surgical site infection
rates in patients with a HbA1C below 7.5% was 2.8%. Surgical site infection rates in patients
with a HbA1C above 7.5% was 6.46%. Showen et al. (2017) agreed with the general consensus
that there is limited data on the use of glycemic status to predict surgical site infection risk for
surgeons. If surgeons used data that included measurements of HbA1c to help determine when it
is favorable to operate the outcome could lead to less complications and infections in the postoperative stage. Analysis of the study done at the UCLA Medical Center in California found that
there was a significantly positive association between preoperative HbA1c greater than 7% and
surgical site infections (Showen et al., 2017). Chen et al. (2018) made the recommendation for
future surgeries in suggesting that utilization of A1c may help predict difficult cases of
uncontrolled postoperative glucose and postsurgical complications. Their study evaluated type 2
diabetics scheduled for elective surgeries. Group A had an A1c less than 7% and Group B had
A1c greater than or equal to 7%. In the first week of postoperative time, nine out of fifty patients
developed surgical site infections or surgical wound complications, one developed a urinary tract
infection, and one had hospital-acquired pneumonia. Of the eleven total patients that developed
an infection or complication, 10 patients were from group B and one was from Group A (Chen et
al., 2018). This translates to elevated risk for a type 2 diabetic to develop postoperative
complications if their HbA1c is greater than or equal to 7%. All of the prior stated studies can
show relevance to the concept that
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Although it is widely accepted that hyperglycemia in the perioperative period is
associated with surgical site infections and other complications after surgery, tight
glycemic control in the postoperative period may act as a double-edged sword, increasing
the risk of hypoglycemia and its associated higher mortality. (Chen et al., 2018)
In the study done by Chen at al. (2018) the median HbA1c of those who developed
complications was 7.9%. The median HbA1c of those who did not develop complications was
6.5%. This leads to a conclusion that the goal for treatment would follow the AACE’s guidelines.
Non-Surgical Infections
Other situations not related to surgery are also pertinent in the assessment of infection
risk. The highest causes of infection are cellulitis, urinary infections, digestive infections, and
septicemia (Li & McDermott, 2016). Wound infections, including cellulitis or poor wound
healing remain a top concern for diabetics. One risk factor for wound complications and
infection is peripheral neuropathy. Half of patients with T2DM have peripheral neuropathy
(Peterson et al., 2017). When neuropathy is combined with reduced blood flow, neuropathy in
the feet increases the risk of foot ulcers, infection and may even lead to limb amputation.
Peterson et al. (2017) suggests that HbA1c can predict nerve degeneration and regeneration. The
final result of the study conducted over a 10-year period of time was that a 1% increase in
HbA1c was associated with a 1% decrease in amplitude of nerve conduction (Peterson et al.,
2017). As stated prior, T2DM patients are at higher risk for wound healing complications so
when the factor of neuropathy is added there is a significantly higher risk for wounds in the first
place. Mor et al. (2017) had an interesting study because their analysis looked into HbA1c less
than 7% at 0.5 percent increments. They also looked at HbA1c greater than 7.5% and greater at
0.5 percent increments. They found that there was an increased risk of infection for HbA1c
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levels below 5.50%, and higher than 7.5%. This is data that was not found elsewhere in this
literature review, because there was limited studies that analyzed below the guidelines treatment
goal of 7% HbA1c. They reported that the patient group less than 5.50% was younger than the
other patients and had higher numbers of comorbidities attributed to alcoholism-related
conditions.
Inconclusive Evidence
Of the thirteen articles reviewed four of the articles did not show enough significant data
to prove there was an association of increased risk of infection with elevated HbA1c levels.
Zubair et al. (2018) had an analysis that included several factors and how they affect healing
process of ulcers in diabetic patients. One of the elements they analyzed was HbA1c. They found
there was an insignificant correlation of HbA1c with ulcer healing rates. Cellulitis is a soft tissue
infection that often starts out from an ulceration, as seen in the case study patient in this review.
In a study done by Wijayaratna et al. (2016) that focused on hospital admission for T2DM with
lower extremity cellulitis, the average HbA1c for patients with cellulitis was 7.7%. Of their
entire study, 22% of all lower limb cellulitis admissions were type 2 diabetics. HbA1c was not
related to the risk of readmission for ulcer-related complications in type 2 diabetics. T2DM was a
factor in longer length of hospitalizations but the relation between ulceration complication and
glycemic control was not significant (Wijayaratna et al., 2016).
In regard to other types of infections such as those related to the eye, there was no
association found with glycemic control (Ansari et al., 2017). Infections such as blepharitis,
styes, periorbital cellulitis, keratitis, and lacrimal gland infection were all included on the study.
The study was in agreement with common knowledge that eye infections, especially
conjunctivitis, is recorded more frequently in T2DM patients, but “infection risk was in no way
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found to be associated with the degree of glycemic control” (Ansari et al., 2017). Several times
throughout the article by Ansari et al. (2017) the idea that there was simply not enough data to
support the hypothesis that strict glycemic control affects infection rates was stated.
The review of an article related to total knee arthroplasty in diabetics did show a
correlation among the level of HbA1c and surgical site infections (Hwang, 2015), but the
correlation was not within strict glycemic control when using either the ADA or AACE
guidelines. The conclusion from Hwang (2015) was that a HbA1c greater than or equal to 8%
was associated with decreased amount of surgical site infections. Another reference used studied
patients with Cystic Fibrosis-Related Diabetes (CFRD) compared to patients with Cystic Fibrosis
(CF) without DM (Belle-van Meerkerk et al., 2016). In the study 39% of patients with CF were
also diagnosed with CFRD and 81% of these patients with CFRD achieved target glycemic
control of 7.0%. They found that infection rates were increased with certain bacteria, with lower
lung functioning, and with CFRD, but did not find any correlation to well-controlled HbA1c
itself (Belle-van Meerkerk et al., 2016).
A review by Pearson-Stuttard et al. (2015) included 13 studies to evaluate the association
of glycemic control. One study they reviewed found that patients with a HbA1c greater than 7%
was associated with higher antibiotic prescription that patients with HbA1c less than 7%. Their
data analysis also reported that there was a small but non-significant difference in HbA1c at
baseline in patients who were admitted to the hospital for infection. They concluded with the
statement that, “evidence suggests that better glycemic control might reduce infection risk, but
further longitudinal studies with more frequent measures of HbA1c are needed” (PearsonStuttard et al., 2015).
Discussion
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This literature review has shown to have mixed conclusions. The majority of the articles
used to evaluate the posed question of does a strict glycemic control affect the risk of infection
provided evidence that reduces infection risk. This means that the closer a HbA1c is to either
6.5% or 7% in accordance with ADA and AACE guidelines, the lower the risk of infection.
There were not enough studies to evaluate the significance of HbA1c lower than 7%. In the
future, research will need to be conducted more narrowly to evaluate the infection risk when
comparing the two guidelines to see which is most beneficial to the patient. If healthcare is able
to give a clearer reason as to why we need patients to be in more control of their diabetes due to
complication risk with surgery, or due to risk of infection they are more apt to obey the
guidelines in theory.
Learning Points
•

Diabetes alone is a risk factor for infection. Elevation of HbA1c greater than 7%
increases risk for infection in addition to the sole diagnosis of diabetes.

•

At this time there is limited data used to predict surgical site infection risk. By getting
a HbA1c within 30 days of surgery, surgeons would be able to better identify those at
higher risk for infection or wound complications.

•

Currently there is not enough data to report what the most suitable HbA1c level is to
consolidate the two guidelines of the American Association of Clinical
Endocrinologists and the American Diabetes Association. Further research needs to
be done to evaluate HbA1c less than 7% to determine if there is more significant
association with infection rates decreasing with levels less than 7%.
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